SRPT Q4 2017 Earnings — Sarepta Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

SRPTSarepta Therapeutics, Inc.

$2B

Q4 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$57M+956.6% YoY

Gross Profit

$54M93.8% margin

Operating Income

-$23M-40.4% margin

Net Income

-$24M-41.9% margin

EPS (Diluted)

$-0.37

QoQ Revenue Growth

+24.6%

Cash Flow

Operating Cash Flow

-$31M

Free Cash Flow

-$36M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$1.3B

Total Liabilities

$519M

Stockholders' Equity

$789M

Cash & Equivalents

$600M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$57M	$5M	+956.6%
Gross Profit	$54M	$5M	+915.5%
Operating Income	-$23M	-$88M	+73.8%
Net Income	-$24M	-$88M	+72.9%